Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $26.3150 (6.54%) ($26.3150 - $26.3150) on Mon. Dec. 7, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 92 | Latest Price | $26.3150(6.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 2.7% a day on average for past five trading days. | Weekly Trend | ATRA advances 7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -2.095% in a week (0% probabilities). VIXM(-33%) VXX(-26%) UNG(-10%) TLT(-9%) UUP(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $24.38(7.94%) | 10 Day Moving Average | $23.84(10.38%) | 20 Day Moving Average | $21.48(22.51%) | To recent high | 0% | To recent low | 109.7% | Market Cap | $1.955b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |